Noteworthy

Jul 07, 2018
Pharmaceutical Executive
Streamlined clinical research, more guidance speed new cures to patients. Jill Wechsler reports.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 30, 2018
Ron Wince explains how Pragmatic AI allows organizations to start with the basics, create immediate business value and ROI and then increase adoption as their comfort, capabilities and confidence increases.
Jun 23, 2018
Realistic, multisensory training devices can contribute to a drug’s reception in the eyes of both patients and healthcare practitioners, writes Paul Sullivan.
Jun 22, 2018
Josh Reisberg outlines the foundation of a broad defense strategy for generic companies embroiled in Hatch-Waxman litigations.
Jun 21, 2018
China's nurse educator program aims to improve quality of care and make life simpler for physicians handling high patient load. Sebastian Bather reports.
Jun 20, 2018
Pharmaceutical Executive
Azar and Gottlieb out front in revising rebates, restructuring Medicare, and promoting competition. Jill Wechsler reports.
Jun 19, 2018
On May 1, China eliminated the tariff on 28 categories of imported drugs. Jin Zhang looks at the implications for foreign and domestic pharma companies.
Jun 18, 2018
Pharmaceutical Executive
Exploring new character benchmarks for today’s pharma executives, and whether they have the transformational traits to lead through change.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
native1_300x100
lorem ipsum